Latest news
Top Generate Biomedicines (GENB) Competitors 2026 - MarketBeatMarketBeat · Mon, 10 Aug 2026 04:50:19 GMTPiper Sandler Maintains Generate Biomedicines(GENB.US) With Buy Rating, Maintains Target Price $24 - MoomooMoomoo · Fri, 07 Aug 2026 12:38:00 GMTGenerate Biomedicines (GENB) Stock Trends and Sentiment 2026 - MarketBeatMarketBeat · Fri, 07 Aug 2026 11:35:39 GMTGenerate Biomedicines, Inc. (GENB) stock price, news, quote and history - Yahoo Finance UKYahoo Finance UK · Fri, 07 Aug 2026 01:30:58 GMTGenerate Biomedicines Shares Fall Following Q2 Financial Results - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 17:51:19 GMTPress Release: Generate Biomedicines Inc. Reports Second Quarter 2026 Financial Results and Provides Business Update - MoomooMoomoo · Thu, 06 Aug 2026 11:00:00 GMTGenerate Biomedicines reports Q2 2026: $6.3M revenue, $67.3M net loss, $457.4M cash - TradingViewTradingView · Thu, 06 Aug 2026 10:13:01 GMTGenerate Biomedicines, Inc. Q2 2026: Revenue $6.3M, EPS $(0.52) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 10:11:01 GMT